ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philip I. Hornick
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wallitt, E. J.W.
Right arrow Articles by Hornick, P. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallitt, E. J.W.
Right arrow Articles by Hornick, P. I.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2007;84:317-323
© 2007 The Society of Thoracic Surgeons

Reviews

Therapeutics of Vein Graft Intimal Hyperplasia: 100 Years On

Edward J.W. Wallitt, BSc, Marc Jevon, PhD, Philip I. Hornick, FRCS*

Department of Cardiothoracic Surgery, Imperial College, London, United Kingdom

* Address correspondence to Mr Hornick, Department of Cardiothoracic Surgery, NHLI, Imperial College, Hammersmith Campus, 2nd Floor, B Block, DuCane Rd, London, W12 0NN, United Kingdom (Email: p.hornick{at}imperial.ac.uk).

Intimal hyperplasia is central to the pathology of vein graft re-stenosis, and despite considerable advances in our understanding of vascular biology since it was first described 100 years ago, it is still a significant clinical problem. Recent decades have seen the development of many new therapeutic agents aimed at treating this condition, but the successes of laboratory studies have not been replicated in the clinic yet. This review discusses these therapeutic agents, how their modes of action relate to the pathogenesis of vein graft intimal hyperplasia, and considerations of ways in which such therapy may be improved in the future.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
S. A. Olenchock Jr, D. Karmpaliotis, W. J. Gibson, S. A. Murphy, M. C. Southard, L. Ciaglo, J. Buros, M. J. Mack, J. H. Alexander, R. A. Harrington, et al.
Impact of Saphenous Vein Graft Radiographic Markers on Clinical Events and Angiographic Parameters
Ann. Thorac. Surg., February 1, 2008; 85(2): 520 - 524.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.